Cargando…

Long-Term Efficacy and Low Adverse Events of Methylprednisolone Pulses Combined to Low-Dose Glucocorticoids for Systemic Sclerosis: A Retrospective Clinical Study of 10 Years’ Follow-Up

BACKGROUND: Patients with systemic sclerosis (SSc) have poor prognosis without cure methods. We began, 10 years ago, to relieve active SSc using short-term intravenous high-dose methylprednisolone pulse (MP-Pulse) and then maintain remission using long-term and low-dose oral glucocorticoids (LTLD-GC...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cheng, Hao, Yu, Zhen, Yan, Cheng-lan, Yang, Hui-dan, Gao, Chong, Wen, Hong-yan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9359792/ https://www.ncbi.nlm.nih.gov/pubmed/35958185 http://dx.doi.org/10.2147/JIR.S373387

Ejemplares similares

Long-Term Efficacy and Low Adverse Events of Methylprednisolone Pulses Combined to Low-Dose Glucocorticoids for Systemic Sclerosis: A Retrospective Clinical Study of 10 Years’ Follow-Up [Letter]
por: Xie, Mingrui
Publicado: (2022)

A COMPARISON OF PULSE METHYLPREDNISOLONE TO LOW-DOSE METHYLPREDNISOLONE IN CRITICALLY-ILL PATIENTS WITH SARS-COV-2 PNEUMONIA: RETROSPECTIVE, OBSERVATIONAL STUDY
por: Bidin, F.N., et al.
Publicado: (2023)

Adverse reaction of methylprednisolone pulse therapy: Acute respiratory distress syndrome
por: Ashtari, Fereshteh, et al.
Publicado: (2021)

Liver injury after pulsed methylprednisolone therapy in multiple sclerosis patients
por: Nociti, Viviana, et al.
Publicado: (2018)

Infantile hemangioendothelioma treated with high dose methylprednisolone pulse therapy.
por: Park, E. A., et al.
Publicado: (2001)

High-Dose Methylprednisolone Pulses for 3 Days vs. Low-Dose Dexamethasone for 10 Days in Severe, Non-Critical COVID-19: A Retrospective Propensity Score Matched Analysis
por: Mora-Luján, José María, et al.
Publicado: (2021)

Is the treatment with pulses of methylprednisolone safe?
por: Bednarczuk, Tomasz, et al.
Publicado: (2013)

Prolonged Low-Dose Methylprednisolone in Patients With Severe COVID-19 Pneumonia
por: Salton, Francesco, et al.
Publicado: (2020)

Low-dose methylprednisolone treatment in critically ill patients with severe community-acquired pneumonia
por: Meduri, G. Umberto, et al.
Publicado: (2022)

Effect of pulsed intravenous methylprednisolone with alternative low-dose prednisone on high-risk IgA nephropathy: a 18-month prospective clinical trial
por: Li, Yan, et al.
Publicado: (2022)

Low-Dose Intravenous Methylprednisolone in Remission Induction Therapy for ANCA-Associated Vasculitis
por: Floyd, Lauren, et al.
Publicado: (2023)

Adverse events related to low dose corticosteroids in autoimmune hepatitis
por: van den Brand, Floris F., et al.
Publicado: (2019)

Hepatotoxicity after high‐dose intravenous methylprednisolone in multiple sclerosis patients
por: Hidalgo de la Cruz, Milagros, et al.
Publicado: (2017)

Immunoadsorption versus double-dose methylprednisolone in refractory multiple sclerosis relapses
por: Pfeuffer, Steffen, et al.
Publicado: (2022)

Methylprednisolone alleviates multiple sclerosis by expanding myeloid‐derived suppressor cells via glucocorticoid receptor β and S100A8/9 up‐regulation
por: Wang, Zhongkun, et al.
Publicado: (2020)

Use of Single- or Two-dose Pulse Methylprednisolone in the Treatment of Acute Immune Thrombocytopenic Purpura
por: Turhan, Ayşe Bozkurt, et al.
Publicado: (2018)

Efficacy and safety of belimumab/low-dose cyclophosphamide therapy in moderate-to-severe systemic lupus erythematosus
por: Cheng, Hao, et al.
Publicado: (2022)

Efficacy and safety of low dose oral prednisolone as compared to pulse intravenous methylprednisolone in managing moderate severe Graves’ orbitopathy: A randomized controlled trial
por: Roy, Ajitesh, et al.
Publicado: (2015)

Pulse methylprednisolone in allergic bronchopulmonary aspergillosis exacerbations
por: Singh Sehgal, Inderpaul, et al.
Publicado: (2014)

Efficacy and Safety of Methotrexate in Combination with Mini Pulse Doses of Methylprednisolone in Severe Alopecia Areata. The Vietnamese Experience
por: Van, Anh Tran Thi, et al.
Publicado: (2019)

Low- Versus High-Dose Methylprednisolone in Adult Patients With Coronavirus Disease 2019: Less Is More
por: Joshi, Seema, et al.
Publicado: (2021)

Methylprednisolone Plus Low-Dose Methotrexate for Bullous Pemphigoid—A Single Center Retrospective Analysis
por: Gravani, Agoritsa, et al.
Publicado: (2022)

Retrospective analysis of leflunomide and low-dose methylprednisolone for the treatment of diabetic nephropathy combined with membranous nephropathy
por: Shang, Shunlai, et al.
Publicado: (2022)

In vitro inhibition of HUVECs by low dose methotrexate – insights into oral adverse events
por: Annussek, Tobias, et al.
Publicado: (2014)

A retrospective observational study of glucocorticoid-induced diabetes mellitus with IgA nephropathy treated with tonsillectomy plus methylprednisolone pulse therapy
por: Miyawaki, Yoshia, et al.
Publicado: (2017)

PULSED METHYLPREDNISOLONE USAGE IN ARDS DUE TO VIRAL PNEUMONIA
por: Szeto, C.H.
Publicado: (2019)

Intravenous pulse methylprednisolone for the treatment of severe COVID-19
por: Patoulias, Dimitrios, et al.
Publicado: (2023)

Effects of Short-Term Low-Dose Glucocorticoids for Patients with Mild COVID-19
por: Fu, Hai-Yan, et al.
Publicado: (2020)

Pulse dexamethasone therapy versus pulse methylprednisolone therapy for treatment of Graves's ophthalmopathy
por: Philip, Rajeev, et al.
Publicado: (2013)

Glucocorticoid management in rheumatoid arthritis: morning or night low dose?
por: Paolino, Sabrina, et al.
Publicado: (2017)

Use of Pulsed Low–Dose Rate Radiotherapy in Refractory Malignancies()()
por: Yan, Jing, et al.
Publicado: (2018)

A comparison of the analgesic efficacy of transforaminal methylprednisolone alone and with low doses of clonidine in lumbo-sacral radiculopathy
por: Tauheed, Nazia, et al.
Publicado: (2014)

Short and long-term effects of high-dose intravenous methylprednisolone pulse therapy on thyroid-associated ophthalmopathy
por: Liu, Xiaomei, et al.
Publicado: (2016)

Herpes Simplex Virus Meningoencephalitis Following Pulse-Dose Methylprednisolone: A Case Report and Literature Review
por: Horn, Jeffrey, et al.
Publicado: (2021)

The impact of low-dose glucocorticoids on disease activity, bone mineral density, fragility fractures, and 10-year probability of fractures in patients with rheumatoid arthritis
por: Cheng, Tien-Tsai, et al.
Publicado: (2018)

Lymphocytic Hypophysitis with Diabetes Insipidus: Improvement by Methylprednisolone Pulse Therapy
por: Jo, Young-Suk, et al.
Publicado: (2004)

Methylprednisolone pulse therapy: An alternative management of severe COVID-19
por: Sauñe, Patricia Merab, et al.
Publicado: (2020)

Methylprednisolone pulse therapy for refractory Mycoplasma pneumoniae pneumonia in children
por: Tamura, Akihiro, et al.
Publicado: (2008)

Prolonged low-dose methylprednisolone treatment is highly effective in reducing duration of mechanical ventilation and mortality in patients with ARDS
por: Meduri, Gianfranco Umberto, et al.
Publicado: (2018)

Neuroprotective effect of combining tanshinone IIA with low-dose methylprednisolone following acute spinal cord injury in rats
por: Yao, Nian-Wei, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_3s3ra6th0b20fh097g18q63c1j